Surgery as an adjunctive treatment for multidrug-resistant tuberculosis: An individual patient data metaanalysis

Clinical Infectious Diseases

Volumn 62, Issue 7, 2016, Pages 887-895

  Fox, Gregory J ^a   Mitnick, Carole D ^b   Benedetti, Andrea ^a   Chan, Edward D ^c   Becerra, Mercedes ^b   Chiang, Chen Yuan ^d   Keshavjee, Salmaan ^b   Koh, Won Jung ^e   Shiraishi, Yuji ^f   Viiklepp, Piret ^g   Yim, Jae Joon ^h   Pasvol, Geoffrey ⁱ   Robert, Jerome ^j   Shim, Tae Sun ^k   Shin, Sonya S ^l   Menzies, Dick ^a  

^a MCGILL UNIVERSITY   (Canada)

^b HARVARD MEDICAL SCHOOL   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^e Samsung Medical Center   (South Korea)

^f Japan Anti Tuberculosis Association   (Japan)

^g National Institute for Health Development   (South Korea)

^h Seoul National University   (South Korea)

ⁱ IMPERIAL COLLEGE LONDON   (United Kingdom)

^j SORBONNE UNIVERSITÉ   (France)

^k University of Ulsan   (South Korea)

^l BRIGHAM AND WOMEN S HOSPITAL   (United States)

more..

Author keywords

individual patient data; metaanalysis; multidrug resistant tuberculosis; pneumonectomy; thoracic surgery

Indexed keywords

ARTICLE; COHORT ANALYSIS; DEATH; FOLLOW UP; HUMAN; LOBECTOMY; LUNG RESECTION; META ANALYSIS; MULTIDRUG RESISTANT TUBERCULOSIS; PATIENT CODING; PRIORITY JOURNAL; PROPENSITY SCORE; RELAPSE; SEGMENTECTOMY; SURGICAL PATIENT; SYSTEMATIC REVIEW; TREATMENT DURATION; TREATMENT OUTCOME; ADULT; FEMALE; MALE; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; STATISTICS AND NUMERICAL DATA; TUBERCULOSIS, MULTIDRUG-RESISTANT; TUBERCULOSIS, PULMONARY;

TUBERCULOSTATIC AGENT;

ADULT; ANTITUBERCULAR AGENTS; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MALE; MIDDLE AGED; PNEUMONECTOMY; TREATMENT OUTCOME; TUBERCULOSIS, MULTIDRUG-RESISTANT; TUBERCULOSIS, PULMONARY;

EID: 84963944157     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/ciw002     Document Type: Article

References (17)

1. Abubakar I, Zignol M, Falzon D, et al. Drug-resistant tuberculosis: time for visionary political leadership. Lancet Infect Dis. 2013; 13: 529-39.
2. World Health Organization. Guidelines for the programmatic management of drug-resistant tuberculosis. Geneva: WHO, 2011.
3. Wu S, Zhang Y, Sun F, et al. Adverse events associated with the treatment of multidrug-resistant tuberculosis: a systematic review and meta-Analysis. Am J Ther. 2013; doi: 10.1097/01.mjt.0000433951.09030.5a.
4. Odell JA. The history of surgery for pulmonary tuberculosis. Thorac Surg Clin. 2012; 22: 257-69.
5. World Health Organization Regional Office for Europe. The role of surgery in the treatment of pulmonary tuberculosis and multidrug- And extensively drug-resistant tuberculosis. Geneva: WHO, 2014.
6. Dara M, Sotgiu G, Zaleskis R, Migliori GB. Untreatable tuberculosis: is surgery the answer?. Eur Respir J. 2015; 45: 577-82.
7. Calligaro GL, Moodley L, Symons G, Dheda K. The medical and surgical treatment of drug-resistant tuberculosis. J Thorac Dis. 2014; 6: 186-95.
8. Ahuja SD, Ashkin D, Avendano M, et al. Multidrug resistant pulmonary tuberculosis treatment regimens and patient outcomes: an individual patient data metaanalysis of 9, 153 patients. PLOS Med. 2012; 9: e1001300.
9. Xu HB, Jiang RH, Li L. Pulmonary resection for patients with multidrug-resistant tuberculosis: systematic review and meta-Analysis. J Antimicrob Chemother. 2011; 66: 1687-95.
10. Marrone MT, Venkataramanan V, Goodman M, Hill AC, Jereb JA, Mase SR. Surgical interventions for drug-resistant tuberculosis: a systematic review and metaanalysis. Int J Tuberc Lung Dis. 2013; 17: 6-16.
11. Johnston JC, Shahidi NC, Sadatsafavi M, Fitzgerald JM. Treatment outcomes of multidrug-resistant tuberculosis: a systematic review and meta-Analysis. PLoS One. 2009; 4: e6914.
12. Hannink G, Gooszen HG, van Laarhoven CJ, Rovers MM A systematic review of individual patient data meta-Analyses on surgical interventions. Syst Rev. 2013; 2: 52.
13. Orenstein EW, Basu S, Shah NS, et al. Treatment outcomes among patients with multidrug-resistant tuberculosis: systematic review and meta-Analysis. Lancet Infect Dis. 2009; 9: 153-61.
14. Ackcakir Y. Correlates of treatment outcomes of multidrug-resistant tuberculosis (MDR-Tuberculosis): a systematic review and meta-Analysis. Montreal, Canada: McGill University, 2010.
15. Laserson KF, Thorpe LE, Leimane V, et al. Speaking the same language: treatment outcome definitions for multidrug-resistant tuberculosis. Int J Tuberc Lung Dis. 2005; 9: 640-5.
16. DerSimonian R, Laird N. Meta-Analysis in clinical trials. Control Clin Trials. 1986; 7: 177-88.
17. Jackson D, White IR, Riley RD. Quantifying the impact of between-study heterogeneity in multivariate meta-Analyses. Stat Med. 2012; 31: 3805-20.